MFC KRX:432980KOSDAQ
엠에프씨 · Korean news coverage and regulatory filings, organized.
Articles, 24h7
Articles, 7 days7
DART filings, 7 days0
Articles tracked14since Sep 11
In Q2 2026, MFC reported revenue of ₩6.0bn, up 10.9% year on year, and operating profit of ₩239m. MFC (엠에프씨) appeared in 7 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 1 with 7 articles. It was most often mentioned alongside Yuhan and Quratis.
MFC quarterly results separate, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩6.0bn | +10.9% | ₩239m margin 4.0% | ₩300m |
| Q1 2026 | ₩3.2bn | -45.8% | −₩347m margin −10.9% | −₩565m |
| Q4 2025 derived | ₩5.0bn | +14.3% | −₩454m margin −9.1% | −₩156m |
| Q3 2025 | ₩4.5bn | -0.6% | ₩1m margin 0.0% | −₩188m |
| Q2 2025 | ₩5.4bn | -16.1% | ₩643m margin 11.9% | ₩1.1bn |
| Q1 2025 | ₩5.9bn | +11.2% | ₩107m margin 1.8% | ₩32m |
| Q4 2024 derived | ₩4.4bn | – | −₩732m margin −16.7% | −₩2.2bn |
| Q3 2024 | ₩4.5bn | – | ₩300m margin 6.6% | ₩310m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
MFC top stories 2 weeks, by number of outlets
- 1
- 2
- 3
- 4
Latest MFC news Korean headlines
-
엠에프씨, 유한양행 출신 현창근 상무 영입…AI완제사업본부장 선임
5 more on this story · 4 outlets
- 엠에프씨, 유한양행 출신 현창근 상무 영입…AI완제사업본부장 선임이데일리 · 08:42
- 엠에프씨, 유한양행 출신 현창근 상무 영입…AI완제사업본부장 선임이데일리 · 08:44
- 엠에프씨, 유한양행 출신 현창근 상무 영입…AI 완제의약품 사업 속도더바이오 · 09:44
- 엠에프씨, 유한양행 출신 현창근 상무 영입…AI 완제의약품 사업 확대바이오타임즈 · 10:54
- 엠에프씨, 유한양행 출신 현창근 상무 영입뉴스핌 · 14:49
-
Obesity, Diabetes Stocks Rally Hard as Quratis and MFC Lock in Daily Limit Gains[K-Bio Pulse]
1 more on this story · 1 outlets
-
비만·당뇨 치료제 테마주 강세… 큐라티스·엠에프씨 상한가 [바이오맥짚기]
1 more on this story · 1 outlets
- 비만·당뇨 치료제 테마주 강세… 큐라티스·엠에프씨 상한가 [바이오맥짚기]이데일리 · Sep 18 08:12